Evidence map›Paper›PMID 34926230›Full record

ArticleGland surgery2021

Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.

Yufan Wei, Liming Ding, Xin Song, Xia Tian, Ningning Min, Qingyu Guan, Xiru Li, Mei Liu

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Gland surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Codon 172 in theGland surgery · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yufan Wei *School of Medicine, Nankai University, Tianjin, China.
Liming Ding *Department of Pathology, Yi'an District People's Hospital, Tongling, China.
Xin Song *Department of Pathology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Xia TianDepartment of Pathology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Ningning MinSchool of Medicine, Nankai University, Tianjin, China.
Qingyu GuanSchool of Medicine, Nankai University, Tianjin, China.
Xiru LiDepartment of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Mei LiuDepartment of Pathology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tall cell carcinoma with reversed polarity (TCCRP) is an extremely rare type of invasive breast cancer with only 17 literatures and 75 cases reported. Knowledge on TCCRP is still scanty. The present study reported 2 cases of TCCRP, analyzed their clinicopathological characteristics, and used whole exome sequencing to perform genetic testing. Both two cases were proved to have typical clinicopathological manifestations (solid and papillary architectures lined by tall columnar cells with nuclei displaying "reverse polarization") and hotspot mutations (

Indexed as

breast cancercase reportgenetic testingIDH2 mutationTall cell carcinoma with reversed polarity (TCCRP)

Identifiers

PMID34926230
PMCPMC8637072
OpenAlexW3213629317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.